Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Address any behavioral patterns (stress eating, poor sleep, alcohol) that intensified after medication changes
To reflect the chronic and relapsing nature of obesity disease, the following 3 retreatment scenarios were evaluated
Its essential to monitor these side effects and inform your healthcare provider if they persist or worsen
GLP-1 receptor agonists are a class of FDA-approved medications that mimic this hormone, producing three powerful effects: Appetite suppression signals your brain that youre full sooner and for longer Slowed gastric emptying food moves through your stomach more slowly, reducing hunger spikes Blood sugar regulation stimulates insulin release in response to meals, supporting metabolic health Originally developed for type 2 diabetes management, GLP-1 medications have since been FDA-approved specifically for chronic weight management in adults with obesity or overweight and related health conditions
